Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03765918
Brief Title: Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)

First Submitted : November 6, 2018
First Submitted that Met QC Criteria : December 4, 2018
First Posted : December 5, 2018

Last Update Submitted that Met QC Criteria : April 1, 2021
Last Update Posted : April 2, 2021